Evaluation of the Use of Exenatide Once-Weekly Suspension Autoinjector Among Patients With Type 2 Diabetes Mellitus and Health Care Professionals

BACKGROUND: Ease of injection is important to patients. An autoinjector was developed to deliver exenatide, a glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus. For autoinjection, 0.06-mm exenatide-containing microspheres are suspended in medium-chain triglycerides. Herein, we re...

Descripción completa

Detalles Bibliográficos
Autores principales: LaRue, Susan, Springer, Jane, Noderer, Michael, Meehan, James, Wysham, Carol H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399794/
https://www.ncbi.nlm.nih.gov/pubmed/30234374
http://dx.doi.org/10.1177/1932296818798376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399794/
https://www.ncbi.nlm.nih.gov/pubmed/30234374
http://dx.doi.org/10.1177/1932296818798376

Ejemplares similares